Virtual Event (Radcliffe): Benefitting from the Human Genome
Anne Wojcicki, cofounder of 23andMe, will discuss the evolving benefits of genomic science, including the company’s crowdsourced research platform. This platform has played a role in creating one of the largest COVID-19 research studies, and is helping to bring new medicines to patients.
Tuesday, November 17, 2020 @ 1:00PM Pacific Time (4:00PM Eastern Time)
Virtual Event via Zoom (details sent after registration)
Click here for more details and to register now!
In 2006, Anne Wojcicki cofounded 23andMe to help people access, understand, and benefit from the human genome, and she now serves as the company’s CEO. In this Radcliffe Institute program, Wojcicki will discuss the evolving benefits of genomic science, including the company’s crowdsourced research platform. This platform has played a role in creating one of the largest COVID-19 research studies, exploring whether genetics plays a role in the severity or susceptibility to the virus, and is helping to drive the discovery of novel, genetically validated therapeutic targets to bring new medicines to patients.
Anne Wojcicki, cofounder and CEO, 23andMe
Jonathan Zittrain, George Bemis Professor of International Law and vice dean for library and information resources, Harvard Law School; faculty director, Berkman Klein Center for Internet & Society at Harvard University; professor of computer science, Harvard John A. Paulson School of Engineering and Applied Sciences; and professor, Harvard Kennedy School
1:00PM - 2:00PM Tue 17 Nov 2020, Pacific timezone
Virtual Event Instructions: